Valea, F.A. and Katz, V.L. (2007) Breast Diseases: Diagnosis and Treatment of Benign and Malignant Disease. In: Katz, V.L., Lentz, G.M., Lobo, R.A., Gershenson, D.M., Eds., Comprehensive Gynecology, 5th Edition, Pa. Mosby Elsevier, Philadelphia.
http://dx.doi.org/10.1016/B978-0-323-02951-3.50018-2

has been cited by the following article:

• TITLE: The Influence of Progesterone Gel Therapy in the Treatment of Fibrocystic Breast Disease

  AUTHORS: Milena Brkic, Svetlana Vujovic, Maja Franic Ivanisevic, Miomira Ivovic, Milina Tancic Gajic, Ljiljana Marina, Marija Barac, Branko Barac, Alekasandar Djogo, Gabrijela Malesevic, Damir Franic

  KEYWORDS: Progesterone, Mastalgia, Mastodynia, Fibrocystic Breast Disease

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.6 No.5, April 28, 2016

  ABSTRACT: The effect of progesterone therapy on E2/P ratio changes during the luteal phase, and its consequences are on mastalgia and cyst, within a fibrocystic breast disease (FBD). Fifty women with FBD were included. Information for mastalgia and mastodynia were checked with a questionnaire. All women had (E2) and (P) concentration checked before and during the therapy on the 21st and 24th day of a cycle, ultrasound measured size and number of cysts before and during the therapy. T-test, X2-test, McNemar test, Wilcoxon test and Friedman test were used for statistics. There was a decrease E2/P relation during the therapy vs. before the treatment p